1
Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
Condition(s):ADLast Updated:September 29, 2020Completed
Donepezil Hydrochloride 5 Mg: 173 Clinical Trials, Page 1 of 18
Hide Studies Not Open or Pending
2
Neural Correlates In Mild Alzheimer’s Disease
Condition(s):Alzheimer’s DiseaseLast Updated:November 10, 2021Completed
3
Crossover Pharmacokinetic (PK) Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers
Condition(s):Healthy SubjectsLast Updated:May 21, 2021Completed
4
A Study to Evaluate the Effects of MK-0249 and an Alzheimer’s Disease Medication on Cognitive Function in Adults With Alzheimer’s Disease (MK-0249-023)
Condition(s):Alzheimer’s Disease; DementiaLast Updated:October 17, 2018Terminated
5
A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020
Condition(s):Alzheimer DiseaseLast Updated:January 29, 2010Completed
6
A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)
Condition(s):Alzheimer’s DiseaseLast Updated:September 14, 2018Completed
7
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
Condition(s):Cognitive Dysfunction; Memory ImpairmentLast Updated:November 4, 2022Completed
8
A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
Condition(s):Dementia With Lewy Bodies (DLB)Last Updated:February 2, 2016Completed
9
A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.
Condition(s):Down SyndromeLast Updated:August 22, 2017Completed
10
Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer’s Disease on Donepezil
Condition(s):Dementia Alzheimer’s TypeLast Updated:March 14, 2016Completed